World scientific leaders gather in Espoo to accelerate development of bioactive paper
New methods are being developed in Finland, under VTT's direction, for the economical mass production of bioactive paper products, among others based on printing technology. The development is accelerated by organizing a joint conference with Canada's SENTINEL Bioactive Paper Network. The objective of both networks is to develop completely new types of products which e.g. detect and deactivate pathogens like salmonella and SARS.
The cooperation between the Finnish and Canadian networks will be promoted in the conference, which runs from June 24-26, 2008 in Espoo. Nearly 40 representatives of SENTINEL Bioactive Paper Network are joining with the respective amount of Finnish network representatives. The focus of the conference is to find solutions to some of the technical challenges that still exist and on accelerating the development of commercial applications.
SENTINEL's scientific director, and the professor of chemical engineering in Canada Research Chair in Interfacial Technologies and at McMaster University Robert Pelton mentions that one possible application could be for instance a strip of paper which could immediately identify the presence of contaminates in drinking water.
According to Tomi Erho, Senior Rsearch Scientist at VTT, this conference marks an important milestone in developing new bioactive paper products. By joining the forces of a large group of highly skilled researchers and by sharing knowledge and skills, the research parties believe to progress faster towards their goal. Customers may have access to the first simple applications within five years.
Bioactive paper is a product that includes functionalities based on the selective reactions of biomolecules, such as enzymes or antibodies. The application possibilities are extensive and less expensive than products that are in the market today. They consist of e.g. indicators or sensors attached to filters, food product packaging or personal health diagnostics. In printed intelligence applications, the paper's competitiveness lies in the fact that it is biodegradable, which is important in terms of sustainable development.
Topics
Organizations
Other news from the department science
These products might interest you

Cell culture filtration solutions by Cytiva
Cell culture filtration products
High-performance sterile filtration for media, protein purification, and cell culture

Sartopore®2 by Sartorius
Effective mycoplasma removal and sterilisation
Lowest filtration costs and maximum safety for your processes

Sartopore® Platinum by Sartorius
Efficient filtration with minimal protein adsorption
Reduces rinsing volume by 95 % and offers 1 m² filtration area per 10"

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Last viewed contents
Biophysics
David_M._Scienceman
Category:Veins
Deformed_Wing_Virus
Unite_for_Children,_Unite_Against_AIDS
Joints_In_Motion
Nicholas_Georgescu-Roegen
